article thumbnail

Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs

Pharma Mirror

by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.

article thumbnail

Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024

BioPharma Reporter

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges in the industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024

BioPharma Reporter

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at EcoLab Life Sciences to find out what the pharmaceutical manufacturing firm is planning for the event and how it is navigating current challenges in the industry.

article thumbnail

How the New EU AI Act Will Impact Clinical Trials in the Life Sciences?

Cloudbyz

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.

article thumbnail

Report highlights challenges facing life sciences sector amid economic turbulence

Outsourcing Pharma

A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country.

article thumbnail

Challenges of managing PHI & PII Data in Life Sciences and How AI/ML can help

Cloudbyz

The challenge of managing and securing sensitive data, including PHI and PII, is significant for life sciences organizations. At the same time, the regulatory environment is becoming increasingly complex, with new data protection regulations being introduced regularly.